BIO Key Financials
BKYI Stock | USD 0.90 0.02 2.17% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.78 | 0.816 |
|
|
Investors should never underestimate BIO Key's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor BIO Key's cash flow, debt, and profitability to make informed and accurate decisions about investing in BIO Key International.
Net Income |
|
BIO | Select Account or Indicator |
Understanding current and past BIO Key Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BIO Key's financial statements are interrelated, with each one affecting the others. For example, an increase in BIO Key's assets may result in an increase in income on the income statement.
BIO Key Stock Summary
BIO Key competes with LogicMark, SSC Security, ICTS International, Senstar Technologies, and Knightscope. BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.Specialization | Information Technology, Security & Protection Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US09060C3097 |
CUSIP | 09060C408 09060C309 09060C507 78386P104 09060C200 09060C101 |
Location | New Jersey; U.S.A |
Business Address | 101 Crawfords Corner |
Sector | Software |
Industry | Information Technology |
Benchmark | Dow Jones Industrial |
Website | www.bio-key.com |
Phone | 732 359 1100 |
Currency | USD - US Dollar |
BIO Key Key Financial Ratios
Return On Equity | -4.58 | ||||
Profit Margin | (0.92) % | ||||
Operating Margin | (1.45) % | ||||
Price To Sales | 0.41 X | ||||
Revenue | 7.75 M |
BIO Key Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.5M | 22.5M | 17.8M | 11.9M | 4.5M | 4.3M | |
Other Current Liab | 686.9K | 490.9K | 770.4K | 984.5K | 1.2M | 963.2K | |
Net Debt | 2.7M | (16.3M) | (7.5M) | (414.1K) | (146.1K) | (138.8K) | |
Retained Earnings | (89.7M) | (99.5M) | (104.6M) | (114.8M) | (125.0M) | (118.8M) | |
Accounts Payable | 919.3K | 244.2K | 427.8K | 1.1M | 1.3M | 667.1K | |
Cash | 79.0K | 17.0M | 7.8M | 2.6M | 511.4K | 485.8K | |
Inventory | 429.1K | 330.9K | 4.9M | 4.8M | 445.7K | 657.9K | |
Other Current Assets | 108.4K | 201.5K | 216.0K | 342.7K | 364.2K | 346.0K | |
Total Liab | 4.8M | 2.2M | 2.2M | 4.9M | 3.5M | 4.7M | |
Total Current Assets | 1.4M | 18.9M | 14.0M | 9.4M | 2.6M | 5.0M | |
Short Term Debt | 2.4M | 466.3K | 177.2K | 2.9M | 176.6K | 167.7K | |
Common Stock | 1.4K | 782.0 | 786.0 | 919.0 | 103.0 | 97.85 | |
Net Receivables | 236.9K | 903.5K | 1.1M | 1.6M | 1.3M | 1.6M | |
Other Assets | 240.2K | 174.0K | 370.7K | 1.0 | 0.9 | 0.86 | |
Intangible Assets | 228.2K | 1.6M | 1.3M | 1.8M | 1.4M | 2.6M | |
Net Tangible Assets | 3.5M | (2.5M) | 17.5M | 13.0M | 14.9M | 15.7M | |
Capital Surpluse | 80.8M | 85.6M | 87.4M | 119.8M | 137.8M | 88.3M | |
Net Invested Capital | (29.7K) | 20.6M | 15.6M | 9.1M | 1.4M | 1.3M |
BIO Key Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 1.1M | 4.3M | 18K | 30.0K | 218.3K | 207.4K | |
Total Revenue | 2.3M | 2.8M | 5.1M | 7.0M | 7.8M | 5.0M | |
Gross Profit | (193.7K) | 2.0M | 3.4M | 5.0M | 1.4M | 1.4M | |
Operating Income | (6.6M) | (4.9M) | (5.0M) | (9.7M) | (8.8M) | (8.4M) | |
Ebit | (6.6M) | (5.3M) | (5.0M) | (11.9M) | (8.4M) | (8.0M) | |
Research Development | 1.3M | 1.4M | 2.4M | 3.3M | 2.4M | 2.3M | |
Ebitda | (6.6M) | (4.9M) | (4.5M) | (11.4M) | (7.8M) | (7.5M) | |
Cost Of Revenue | 2.5M | 794.8K | 1.7M | 2.0M | 6.3M | 6.6M | |
Net Income | (14.7M) | (13.6M) | (4.6M) | (10.7M) | (8.5M) | (8.1M) | |
Income Tax Expense | 64.3K | 3.9M | (496.1K) | 511.3K | (134.0K) | (140.7K) | |
Income Before Tax | (14.6M) | (9.7M) | (5.1M) | (10.2M) | (8.7M) | (8.2M) | |
Interest Income | 154.0 | 30.6K | 4.1K | 233.0 | 6.0K | 5.7K | |
Net Interest Income | (1.1M) | (4.3M) | (13.9K) | (29.7K) | (1.3M) | (1.4M) |
BIO Key Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | 569.7K | 98.2K | (4.6M) | 106.3K | 402.1K | 422.2K | |
Change In Cash | (244.9K) | 16.9M | (9.2M) | (5.1M) | (2.1M) | (2.0M) | |
Free Cash Flow | (1.9M) | (5.0M) | (9.0M) | (6.3M) | (3.8M) | (4.0M) | |
Depreciation | 1.0M | 426.9K | 514.1K | 546.0K | 590.1K | 624.1K | |
Other Non Cash Items | 1.1M | 4.4M | 128.7K | 5.1M | 4.3M | 4.5M | |
Capital Expenditures | 30.5K | 35.6K | 42.0K | 82.0K | 1K | 950.0 | |
Net Income | (14.6M) | (9.7M) | (5.1M) | (11.9M) | (8.5M) | (8.1M) | |
End Period Cash Flow | 79.0K | 17.0M | 7.8M | 2.6M | 511.4K | 485.8K | |
Change Receivables | (1.1M) | 1.4M | 829.4K | (186.8K) | (214.8K) | (225.5K) | |
Change To Netincome | 1.7M | 7.5M | 1.3M | 724.7K | 833.4K | 791.8K |
BIO Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BIO Key's current stock value. Our valuation model uses many indicators to compare BIO Key value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BIO Key competition to find correlations between indicators driving BIO Key's intrinsic value. More Info.BIO Key International is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . As of now, BIO Key's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BIO Key's earnings, one of the primary drivers of an investment's value.BIO Key International Systematic Risk
BIO Key's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BIO Key volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on BIO Key International correlated with the market. If Beta is less than 0 BIO Key generally moves in the opposite direction as compared to the market. If BIO Key Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BIO Key International is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BIO Key is generally in the same direction as the market. If Beta > 1 BIO Key moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in BIO Key Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BIO Key's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of BIO Key growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
BIO Key December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BIO Key help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BIO Key International. We use our internally-developed statistical techniques to arrive at the intrinsic value of BIO Key International based on widely used predictive technical indicators. In general, we focus on analyzing BIO Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BIO Key's daily price indicators and compare them against related drivers.
Downside Deviation | 8.79 | |||
Information Ratio | 0.018 | |||
Maximum Drawdown | 124.43 | |||
Value At Risk | (12.50) | |||
Potential Upside | 18.31 |
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |